Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Hepatitis C

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 11 articles: HTML format

Single Articles

July 2025
1. KUMARAN L, Gupta S
   Metabolic factors drive early increase in hepatic steatosis despite improvement in non-invasive fibrosis markers after hepatitis C eradication with direct-acting antivirals: Letter to the editor.
   Clin Res Hepatol Gastroenterol. 2025 Jul 28:102662.
   PubMed    
   
   
   June 2025
2. SHENGIR M, Elgretli W, Cinque F, Ramanakumar AV, et al
   Metabolic Factors Drive Early Increase in Hepatic Steatosis Despite Improvement in Non-Invasive Fibrosis Markers after Hepatitis C Eradication with Direct-Acting Antivirals.
   Clin Res Hepatol Gastroenterol. 2025 Jun 16:102639.
   PubMed     Abstract available
   
   
   May 2025
3. KARIYAMA K, Toyoda H, Kumada T, Yasuda S, et al
   Utility of the Fibrosis-3 Index for Predicting Liver Fibrosis 5 Years After Achieving Sustained Virological Response in Patients with Chronic Hepatitis C.
   Clin Res Hepatol Gastroenterol. 2025 May 27:102625.
   PubMed     Abstract available
   
   
   March 2025
4. ABDELMONEIM RS, Sedki F, Bakosh MF
   CHANGES IN THE PRESENTATION AND CHARACTERISTICS OF HCV RELATED HEPATOCELLULAR CARCINOMA IN THE ERA OF DIRECT ANTIVIRAL THERAPY: A RETROSPECTIVE STUDY.
   Clin Res Hepatol Gastroenterol. 2025 Mar 3:102567.
   PubMed     Abstract available
   
   
   October 2024
5. YANG C, Jia J, Yu Y, Lu H, et al
   Temporal trends in prevalence of liver cancer and etiology-specific liver cancer from 1990 to 2019.
   Clin Res Hepatol Gastroenterol. 2024;48:102451.
   PubMed     Abstract available
   
   
   June 2024
6. OLIVEIRA M, Gaspar R, Santos L, Macedo G, et al
   High incidence of hepatocarcinoma in patients with advanced fibrosis treated with direct-acting antiviral agents for hepatitis C: a real-world retrospective study.
   Clin Res Hepatol Gastroenterol. 2024 Jun 18:102404.
   PubMed     Abstract available
   
   
   April 2024
7. SCHEIFER C, Lebrun-Vignes B, Lebray P, Tubach F, et al
   Association between Direct Acting Agents used for chronic hepatitis C virus infection and the occurrence of acute leukaemia - A disproportionality analysis.
   Clin Res Hepatol Gastroenterol. 2024 Apr 27:102356.
   PubMed     Abstract available
   
   
   January 2024
8. PRATA TVG, Paula VG, Passos LO, Brogiato VLB, et al
   Exploring the combined effects of MTTP gene polymorphisms in chronic hepatitis C patients with hepatic steatosis.
   Clin Res Hepatol Gastroenterol. 2024;48:102291.
   PubMed    
   
   
   November 2023
9. PASCALE A, Rosmorduc O, Duclos-Vallee JC
   New epidemiologic trends in cholangiocarcinoma.
   Clin Res Hepatol Gastroenterol. 2023;47:102223.
   PubMed     Abstract available
   
   
   October 2023
10. EL-KASSAS M, Balakosy AE, Elbadry M, Ahmed OA, et al
    The crosstalk between directly acting antivirals and chronic HCV patients with different stages of renal affection: A multicenter study.
    Clin Res Hepatol Gastroenterol. 2023 Oct 20:102232.
    PubMed    
    
    
    June 2023
11. COILLY A, Jasseron C, Legeai C, Conti F, et al
    Impact of direct antiviral agents for hepatitis c virus -induced liver diseases on registration, waiting list and liver transplant activity in France.
    Clin Res Hepatol Gastroenterol. 2023 Jun 23:102168.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.